Conference Coverage

Naloxone Is Frequently Prescribed for Patients With Chronic Pain Taking Opioids


 

References

Studies of Naloxone Are Ongoing
Naloxone is a safe drug with minimal toxicity and is not a controlled substance, noted Dr. Coffin. Naloxone is available in a vial for injection, as an intranasal formulation given off-label, and as an autoinjector specifically designed for administration by nonphysicians that was recently approved by the FDA. Two additional intranasal formulations are being developed.

Randomized, feasibility, and qualitative studies of the naloxone approach are under way. The need to obtain data on the effect of take-home naloxone on events such as opioid analgesic overdoses and on behavior is crucial, concluded Dr. Coffin.

Elizabeth Mechcatie

Pages

Recommended Reading

Handheld vagal nerve stimulator reduced cluster headache attacks
MDedge Neurology
VIDEO: What’s on the horizon for headaches
MDedge Neurology
Amitriptyline beat pregabalin for chronic low back pain
MDedge Neurology
Study finds few data on long-term opioid treatment for chronic pain
MDedge Neurology
FDA approves new abuse-prevention labeling for extended-release Embeda
MDedge Neurology
ACR 2010 criteria for fibromyalgia critiqued
MDedge Neurology
Prescription opioids linked to majority of opioid overdoses
MDedge Neurology
Brain changes identified in chronic fatigue syndrome
MDedge Neurology
Comborbidities likely explain opioid + sleep apnea mortality risk
MDedge Neurology
Opioids for Chronic Noncancer Pain—Risks Outweigh Benefits
MDedge Neurology